BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 5, 2018
View Archived Issues
Liquidia Technologies begins phase III study of LIQ-861
Read More
Mosedipimod receives FDA orphan drug designation for ARS
Read More
Cantex's CX-01 given FDA orphan drug status for AML
Read More
Deciphera Pharmaceuticals' INVICTUS study of DCC-2618 begins
Read More
First patient treated in phase I study of IMGN-632
Read More
Kura presents phase II results of tipifarnib in patients with CMML
Read More
AmpliPhi Biosciences reports topline results from expanded access program for AB-SA01 and AB-PA01
Read More
Asana BioSciences' ASN-002 shows efficacy in atopic dermatitis in proof-of-concept study
Read More
Audentes Therapeutics announces interim results from ASPIRO study of AT-132
Read More
Cortexyme begins phase I program for Alzheimer's disease candidate
Read More
Enrollment begins in phase II/III program for Catalyst Biosciences' marzeptacog alfa
Read More
Alovudine, a POLG inhibitor, shows promise for treating AML
Read More
Boston Pharmaceuticals obtains rights to Pierre Fabre drug candidate for atrial fibrillation
Read More
Janssen Pharmaceutica patents novel PI3Kbeta inhibitors
Read More
FDA awards fast track designation to tafenoquine for malaria
Read More
LifeArc and Suzhou Yabao Pharmaceutical divulge LRRK2 inhibitors
Read More
Shire receives FDA breakthrough therapy designation for maribavir
Read More
Takeda set to acquire TiGenix
Read More
Roche discloses new TLR8 agonists
Read More
WHO prequalifies first typhoid conjugate vaccine
Read More
BioMarin Pharmaceutical presents novel CGT inhibitors
Read More
GeneCentric and G1 Therapeutics establish research collaboration for drug response biomarkers
Read More
Novel KDM5B inhibitors described in Chrysalis patent
Read More
BriaCell updates progress of Bria-IMT trials
Read More
GeoVax collaborates with Vaxeal to expand cancer immunotherapy program
Read More
iTeos Therapeutics regains rights to EOS-200271 from Pfizer
Read More
Anti-GD2 CART approach shows promise for neuroblastoma treatment
Read More